Lysteda was approved in 2009 to treat heavy period bleeding (known as menorrhagia). It is a non-hormonal medication and is only meant to be taken while the woman is menstruating. It is not a birth control and does not protect against sexually transmitted diseases. The drug, known generically as tranexamic acid, works by stabilizing a protein that encourages blood clotting.
According to the label of Lysteda, some women may be at an increased risk of serious blood clots, especially if Lysteda is taken with hormonal contraceptives—the risks further increase if the woman is taking higher than her normal birth control dose—or if the woman is overweight or smokes. Women who take Lysteda are urged to watch for signs of a blood clot and report to their doctor if they suspect a blood clot.
Furthermore, women who have ever had a blood clot or are at risk of developing a blood clot should inform their doctor before they begin taking Lysteda.
READ MORE LYSTEDA LEGAL NEWS
Finally, the Lysteda label warns about the risk of severe allergic reaction, including "dyspnea, tightening of the throat and facial flushing." A report during testing of the drug involved a patient who required emergency treatment for an allergic reaction. A case of anaphylactic shock was also reportedly linked to Lysteda.
Women who experience heavy monthly bleeding may consider using Lysteda to control their bleeding, but should be aware of the risk of side effects when making their decision.
READER COMMENTS
lisa
on